Thomas E. Olencki
Distinguished in WT1-Related Wilms Tumor Syndromes

Dr. Thomas E. Olencki

Oncology
300 W 10th Ave, 
Columbus, OH 

Distinguished in WT1-Related Wilms Tumor Syndromes
300 W 10th Ave, 
Columbus, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Thomas Olencki is an Oncologist in Columbus, Ohio. Dr. Olencki is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Melanoma, Metastatic Uveal Melanoma, Basal Cell Skin Cancer, and Nephrectomy.

His clinical research consists of co-authoring 58 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Oncology
Licenses
Internal Medicine in OH
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

300 W 10th Ave, Columbus, OH 43210
Call: 614-293-8619

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

Phase II Trial of Adjuvant Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy
Phase II Trial of Adjuvant Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy
Enrollment Status: Completed
Publish Date: December 06, 2023
Intervention Type: Drug
Study Drug: Crizotinib
Study Phase: Phase 2
A Phase II Study of MK-3475 in Patients With Advanced Merkel Cell Carcinoma (MCC)
A Phase II Study of MK-3475 in Patients With Advanced Merkel Cell Carcinoma (MCC)
Enrollment Status: Completed
Publish Date: July 05, 2023
Intervention Type: Other, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 2
A Phase II Study of the Efficacy and Safety of Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer After Treatment With Pd-1 or Pd-L1 Inhibitors
A Phase II Study of the Efficacy and Safety of Axitinib Given on an Individualized Schedule for Metastatic Renal Cell Cancer After Treatment With Pd-1 or Pd-L1 Inhibitors
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Drug: Axitinib
Study Phase: Phase 2
A Phase 2 Study of CDX-011 (Glembatumumab Vedotin) for Metastatic Uveal Melanoma
A Phase 2 Study of CDX-011 (Glembatumumab Vedotin) for Metastatic Uveal Melanoma
Enrollment Status: Completed
Publish Date: August 21, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

58 Total Publications

Association between systemic treatment with immune checkpoint inhibitor therapy in renal cell carcinoma and reduced risk of brain metastasis development.
Association between systemic treatment with immune checkpoint inhibitor therapy in renal cell carcinoma and reduced risk of brain metastasis development.
Journal: Neurosurgical focus
Published: February 18, 2023
View All 58 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Edmund Folefac
Oncology | Hematology Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Edmund Folefac
Oncology | Hematology Oncology

Osu Internal Medicine LLC

3900 Stoneridge Ln, 
Dublin, OH 
 (8.2 miles away)
614-366-5001
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Edmund Folefac is an Oncologist and a Hematologist Oncology provider in Dublin, Ohio. Dr. Folefac is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Bone Marrow Aspiration. Dr. Folefac is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. J P. Monk
Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. J P. Monk
Oncology

Osu Internal Medicine LLC

452 W 10th Ave, 
Columbus, OH 
 (0.2 miles away)
614-293-3737
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

J Monk is an Oncologist in Columbus, Ohio. Dr. Monk is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes. Dr. Monk is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Peng Wang
Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Peng Wang
Oncology

Osu Internal Medicine LLC

3900 Stoneridge Ln, 
Dublin, OH 
 (8.2 miles away)
614-366-5001
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

Peng Wang is an Oncologist in Dublin, Ohio. Dr. Wang is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Penile Cancer, Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, and Endoscopy. Dr. Wang is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Olencki's expertise for a condition
ConditionClose
  • Elite
  • Renal Cell Carcinoma (RCC)
    Dr. Olencki is
    Elite
    . Learn about Renal Cell Carcinoma (RCC).
    See more Renal Cell Carcinoma (RCC) experts
  • Distinguished
  • Adult Soft Tissue Sarcoma
    Dr. Olencki is
    Distinguished
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • Basal Cell Skin Cancer
    Dr. Olencki is
    Distinguished
    . Learn about Basal Cell Skin Cancer.
    See more Basal Cell Skin Cancer experts
  • Chromophobe Renal Cell Carcinoma
    Dr. Olencki is
    Distinguished
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Melanoma
    Dr. Olencki is
    Distinguished
    . Learn about Melanoma.
    See more Melanoma experts
  • Melanoma of the Eye
    Dr. Olencki is
    Distinguished
    . Learn about Melanoma of the Eye.
    See more Melanoma of the Eye experts
  • Metastatic Uveal Melanoma
    Dr. Olencki is
    Distinguished
    . Learn about Metastatic Uveal Melanoma.
    See more Metastatic Uveal Melanoma experts
View All 7 Distinguished Conditions
  • Advanced
  • Clear Cell Sarcoma
    Dr. Olencki is
    Advanced
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
  • Familial Wilms Tumor 2
    Dr. Olencki is
    Advanced
    . Learn about Familial Wilms Tumor 2.
    See more Familial Wilms Tumor 2 experts
  • Merkel Cell Carcinoma
    Dr. Olencki is
    Advanced
    . Learn about Merkel Cell Carcinoma.
    See more Merkel Cell Carcinoma experts
  • Neuroendocrine Tumor
    Dr. Olencki is
    Advanced
    . Learn about Neuroendocrine Tumor.
    See more Neuroendocrine Tumor experts
  • Posterior Fossa Tumor
    Dr. Olencki is
    Advanced
    . Learn about Posterior Fossa Tumor.
    See more Posterior Fossa Tumor experts
  • Primitive Neuroectodermal Tumor (PNET)
    Dr. Olencki is
    Advanced
    . Learn about Primitive Neuroectodermal Tumor (PNET).
    See more Primitive Neuroectodermal Tumor (PNET) experts
View All 7 Advanced Conditions
  • Experienced
  • Brain Tumor
    Dr. Olencki is
    Experienced
    . Learn about Brain Tumor.
    See more Brain Tumor experts
  • Fibrosarcoma
    Dr. Olencki is
    Experienced
    . Learn about Fibrosarcoma.
    See more Fibrosarcoma experts
  • Metastatic Brain Tumor
    Dr. Olencki is
    Experienced
    . Learn about Metastatic Brain Tumor.
    See more Metastatic Brain Tumor experts
  • Nephrectomy
    Dr. Olencki is
    Experienced
    . Learn about Nephrectomy.
    See more Nephrectomy experts
  • Squamous Cell Skin Carcinoma
    Dr. Olencki is
    Experienced
    . Learn about Squamous Cell Skin Carcinoma.
    See more Squamous Cell Skin Carcinoma experts
  • Uveal Melanoma
    Dr. Olencki is
    Experienced
    . Learn about Uveal Melanoma.
    See more Uveal Melanoma experts
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved